CLINICAL_TRIALS
trial_result
· 2023-11-13
Clinical Trial Update: Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
Summary
A completed prospective observational analysis evaluating complete remission in renal cell carcinoma patients treated with sunitinib.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Complete Remission in Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2023-11-13